Catalog Products » PIVKA II Antibody (6C4), mAb, Mouse
Manual
Manual
COAs

PIVKA II (6C4), mAb, Mouse

Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as Des-γ-carboxy-prothrombin (DCP), is an abnormal form of prothrombin. Normally, the prothrombin’s 10 glutamic acid residues (Glu) in the γ-carboxyglutamic acid (Gla) domain at positions 6, 7, 14, 16, 19, 20,25, 26, 29 and 32 are γ-carboxylated to Gla by vitamin-K dependent γ- glutamyl carboxylase in the liver and then secreted into plasma. In patients with hepatocellular carcinoma (HCC), γ-carboxylation of prothrombin is impaired so that PIVKA-II is formed instead of prothrombin. PIVKA-II is considered as is an efficient biomarker specific for HCC.
$455.00
V06703-1

Ask us a question
Overview
Specificity Human PIVKA II
Recommended Pairs CLIA (Capture-Detection):
6C4 - 2D7
2D7 - 6C4
Clone ID 6C4
Isotype IgG1 for MAbs 6C4
Subclass IgG1
Host Species Mouse
Antigen Species Human
Back

Properties
Conjugation Unconjugated
Production Cultured in vitro under conditions free from animal-derived components
Purification Protein A/G affinity column
Concentration ≥ 2mg/ml
Formulation 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% ProClin 300.
Storage For long term storage, aliquot and store at -25°C~-15°C or below. Avoid repeated freezing and thawing cycles.
Product Stability
Temperature, Time Result for clone 1C5
-80°C, 21 days OK
-20°C, 21 days OK
4°C, 21 days OK
20°C, 21 days OK
37°C, 21 days OK
40°C, 21 days OK
Note GenScript can customize this product per customer's request including product size, buffer components, etc.
Back

Applications
Platform Capture Detection
CLIA 1C5 2D7
CLIA 6C4 2D7
CLIA 2D7 6C4
Back

PIVKA II (6C4), MAb, Mouse

»

<
>

Background
Target Background Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as Des-γ-carboxy-prothrombin (DCP), is an abnormal form of prothrombin. Normally, the prothrombin’s 10 glutamic acid residues (Glu) in the γ-carboxyglutamic acid (Gla) domain at positions 6, 7, 14, 16, 19, 20,25, 26, 29 and 32 are γ-carboxylated to Gla by vitamin-K dependent γ- glutamyl carboxylase in the liver and then secreted into plasma. In patients with hepatocellular carcinoma (HCC), γ-carboxylation of prothrombin is impaired so that PIVKA-II is formed instead of prothrombin. PIVKA-II is considered as is an efficient biomarker specific for HCC.
Back

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.